P. Ron Ellis, President and CEO at ENDOCYTE INC (ECYT), sold 1,500 shares at $12.00 ($18K) on 2013-03-27, disclosed to the SEC on 2013-03-29.
Scheduled sale ($18k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ECYT | SELL | 2013-10-02 | $40K | — | Filing → |
| ECYT | SELL | 2013-09-05 | $44K | — | Filing → |
| ECYT | SELL | 2013-08-06 | $54K | — | Filing → |